Journal of Medicinal Chemistry · 2019 · 27 citations · 33 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular PharmacologyEnzyme InhibitionLigand BindingMolecular Targets Of DrugsStructure-activity Relationship AnalysisAnnexin V AssaysAnnexin V ImagingChemical Structure-activity RelationshipsCytotoxicity AssaysEnzyme-linked Immunosorbent Assay (Elisa)Nf-κb SignalingOptimization Of Drug-like Properties
The systematic shortening of the noncovalent element of a C8-linked pyrrolobenzodiazepine (PBD) conjugate (13) led to the synthesis of a 19-member library of C8-PBD monomers. The critical elements of 13, which were required to render the molecule cytotoxic, were elucidated by an annexin V assay. The effects of shortening the noncovalent element of the molecule on transcription factor inhibitory capacity were also explored through an enzyme-linked immunosorbent assay-based measurement of nuclear NF-κB upon exposure of JJN-3 cells to the synthesized molecules. Although shortening the noncovalent interactive element of 13 had a less than expected effect upon compound cytotoxicity due to reduced DNA interaction, the transcription factor inhibitory capacity of the molecule was notably altered. This study suggests that a relatively short noncovalent side chain at the C8 position of PBD is sufficient to confer cytotoxicity. The shortened PBD monomers provide a new ADC payload scaffold because of their potent cytotoxicity and drug-like properties.
33
Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
Mónica L. Guzmán, Sarah J. Neering, Donna Upchurch et al. · Blood · 2001 · 757 citations
Medicine, Cell Biology, Oncology +7
Constantine S. Mitsiades, Nicholas Mitsiades, Vassiliki Poulaki et al. · Oncogene · 2002 · 463 citations
Classical and/or alternative NF-κB pathway activation in multiple myeloma
Yulia N. Demchenko, O K Glebov, Adriana Zingone et al. · Blood · 2010 · 289 citations
Medicine, Immunology, Oncology +12